EHS
EHS

New patent expiration for APGDI drug MYRBETRIQ – DrugPatentWatch


Copyright © DrugPatentWatch. Originally published at New patent expiration for APGDI drug MYRBETRIQ


Annual Drug Patent Expirations for MYRBETRIQ

Myrbetriq is a drug marketed by Apgdi and is included in two NDAs. It is available from three suppliers. There are eight patents protecting this drug and one Paragraph IV challenge.

Drug patent litigation for MYRBETRIQ.

The generic ingredient in MYRBETRIQ is mirabegron. Three suppliers are listed for this compound. Additional details are available on the mirabegron profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at New patent expiration for APGDI drug MYRBETRIQ



Source link

EHS
Back to top button